Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Chris Lange | Feb 26, 2020 at 12:25 PM EST

How Novavax Is Differentiating Itself From Other Coronavirus Stocks

Novavax shares made a big step forward on Wednesday after the firm provided an update on its treatment for COVID-19.

Jon C. Ogg | Feb 24, 2020 at 11:15 AM EST

Hope for Gilead’s Remdesivir to Beat the Coronavirus

Gilead Sciences stock surged while the broader market was battered on reports that a senior official from the World Health…

Chris Lange | Feb 24, 2020 at 10:15 AM EST

Natural Hedges for Coronavirus Fear Beating Up the Broad Markets

The broad markets are getting crushed on Monday on renewed fears of the spread of the coronavirus (Covid-19). But a…

Chris Lange | Feb 19, 2020 at 10:10 AM EST

This FDA Approval of Karyopharm’s Lymphoma Treatment Could Be Huge

Karyopharm Therapeutics shares made a handy gain on Wednesday after the firm secured a key FDA nod for its relapsed…

Paul Ausick | Feb 19, 2020 at 7:30 AM EST

Artificial Intelligence and Machine Learning in the Operating Room

Researchers have conducted a trial of a device that alerts anesthesiologists to a possible low-blood-pressure event for patients in surgery.…

Jon C. Ogg | Feb 18, 2020 at 1:15 PM EST

Why Teva’s Grand Turnaround Could Just Be Getting Started

See why Argus believes that Teva Pharmaceutical has made progress concerning its challenges, which are already baked into the stock…

Jon C. Ogg | Feb 18, 2020 at 11:30 AM EST

Why Biogen Fits Well With Warren Buffett and Berkshire Hathaway, Even With Biotech Risks

Investors are not used to hearing is the word "biotech" used in the same sentence as anything to do with…

Douglas A. McIntyre | Feb 18, 2020 at 10:55 AM EST

How Delayed Drug Approval Is Punishing Bio-Path Stock

What is it like to have a stock plunge 90% in less than a year and wipe out a huge…

Chris Lange | Feb 18, 2020 at 10:35 AM EST

Why This Analyst Sees New Contraceptive FDA Approval Doubling Agile Therapeutics Stock

Agile Therapeutics shares took a dip on Tuesday after the company announced a key FDA approval for its new weekly…

Lee Jackson | Feb 18, 2020 at 6:45 AM EST

3 SunTrust Buy-Rated Biotech Stocks Have Massive Upside Potential

These three biotech stocks have gigantic upside and a fair amount of risk as well. While they are not suited…

Chris Lange | Feb 13, 2020 at 11:35 AM EST

Revolution Medicines Enters the Market With a Bang

Revolution Medicines entered the market with a bang on Thursday. Although the company only priced shares are $17 apiece, the…

Chris Lange | Feb 12, 2020 at 10:35 AM EST

Is CVS Back on Track With Q4 Results?

CVS reported better than expected quarterly results before the markets opened on Wednesday, due in part to its acquisition of…

Chris Lange | Feb 12, 2020 at 9:50 AM EST

Big Pharma Sees a Rising Tide in Short Interest

The January 31 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Feb 12, 2020 at 8:45 AM EST

Biotech Short Sellers Focus on a Couple Favorites

The January 31 data has been compared with the previous report, and short interest in most of these selected biotech…

Chris Lange | Feb 11, 2020 at 11:20 AM EST

Is CVS Set to Wow Investors With Q4 Earnings Wednesday Morning?

CVS Health has faced strong headwinds since last year’s acquisition of health insurer Aetna, but its upcoming earnings report could…

1 … 68 69 70 71 72 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

How Novavax Is Differentiating Itself From Other Coronavirus Stocks

Hope for Gilead’s Remdesivir to Beat the Coronavirus

Natural Hedges for Coronavirus Fear Beating Up the Broad Markets

This FDA Approval of Karyopharm’s Lymphoma Treatment Could Be Huge

Artificial Intelligence and Machine Learning in the Operating Room

Why Teva’s Grand Turnaround Could Just Be Getting Started

Why Biogen Fits Well With Warren Buffett and Berkshire Hathaway, Even With Biotech Risks

How Delayed Drug Approval Is Punishing Bio-Path Stock

Why This Analyst Sees New Contraceptive FDA Approval Doubling Agile Therapeutics Stock

3 SunTrust Buy-Rated Biotech Stocks Have Massive Upside Potential

Revolution Medicines Enters the Market With a Bang

Is CVS Back on Track With Q4 Results?

Big Pharma Sees a Rising Tide in Short Interest

Biotech Short Sellers Focus on a Couple Favorites

Is CVS Set to Wow Investors With Q4 Earnings Wednesday Morning?

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

XRP vs Solana vs Ethereum: Which Altcoin is the Best Buy for Upside Right Now?

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

Health and Healthcare Articles

All Health and Healthcare Articles

How Novavax Is Differentiating Itself From Other Coronavirus Stocks

Hope for Gilead’s Remdesivir to Beat the Coronavirus

Natural Hedges for Coronavirus Fear Beating Up the Broad Markets

This FDA Approval of Karyopharm’s Lymphoma Treatment Could Be Huge

Artificial Intelligence and Machine Learning in the Operating Room

Why Teva’s Grand Turnaround Could Just Be Getting Started

Why Biogen Fits Well With Warren Buffett and Berkshire Hathaway, Even With Biotech Risks

How Delayed Drug Approval Is Punishing Bio-Path Stock

Why This Analyst Sees New Contraceptive FDA Approval Doubling Agile Therapeutics Stock

3 SunTrust Buy-Rated Biotech Stocks Have Massive Upside Potential

Revolution Medicines Enters the Market With a Bang

Is CVS Back on Track With Q4 Results?

Big Pharma Sees a Rising Tide in Short Interest

Biotech Short Sellers Focus on a Couple Favorites

Is CVS Set to Wow Investors With Q4 Earnings Wednesday Morning?

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

XRP vs Solana vs Ethereum: Which Altcoin is the Best Buy for Upside Right Now?

Featured Reads

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up